As a leader in developing and commercializing innovative therapies for central nervous system disorders we are committed to improving the lives of patients.
Employees: 501-1000
Total raised: $86.4M
Founded date: 1993
Investors 2
Date | Name | Website |
07.08.2021 | New Enterp... | nea.com |
- | New Leaf V... | nlvpartner... |
Funding Rounds 1
Date | Series | Amount | Investors |
12.12.2012 | - | $86.4M | - |
Mentions in press and media 9
Date | Title | Description | Source |
12.03.2024 | Schizophrenia Trial Failure Ends Acadia’s Efforts to Expand ... | An Acadia Pharmaceuticals drug that’s already approved for treating psychosis in Parkinson’s disease... | medcitynew... |
07.03.2024 | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on... | - | globenewsw... |
07.07.2022 | Pharmacists 'ready to get to work' after new FDA author... | Acadia Pharmaceuticals is putting the power of storytelling to work for Parkinson’s disease. While s... | endpts.com... |
31.08.2020 | Acadia Pharmaceuticals Acquires CerSci Therapeutics | Acadia Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company focused on the development a... | finsmes.co... |
05.12.2019 | Acadia unveils the positive PhIII it's taking to FDA f... | Acadia Pharmaceuticals has broken out the numbers propping up Nuplazid’s surprise early w... | endpts.com... |
20.12.2012 | ACADIA Pharmaceuticals Get Research Funding | ACADIA Pharmaceuticals, which is developing treatments for central nervous system and neurological d... | socaltech.... |
12.12.2012 | ACADIA Pharmaceuticals Gets $86.4M In PIPE | San Diego-based biopharmaceuticals firm ACADIA Pharmaceuticals said today that it has raised $86.4M ... | socaltech.... |
- | Stocks making the biggest moves midday: Apple, Tesla, Starbu... | Check out the companies making headlines in midday trading. Apple — The tech giant saw its shares ju... | cnbc.com/2... |
- | Breaking through | Steve Davis, CEO of ACADIA Pharmaceuticals Life’s important moments are defined by connecting with l... | statnews.c... |